All Stories

  1. Loss of LLGL1 Elevates EGFR/RAS/MAPK Signaling and Remodels EMT Markers in Huh-7 Hepatocellular Carcinoma Cells
  2. LZTR1 Loss Reduces Vimentin Expression and Motility in Hep3B Hepatocellular Carcinoma Cells
  3. Modulation of Oxidative and ER Stress Pathways by the ADAM17 Inhibitor GW280264X in LPS-Induced Acute Liver Injury
  4. AIFM3 Has Pro-apoptotic, Whereas LZTR1 Has Bilateral Functions In The Intrinsic Apoptosis Pathway
  5. The brain-derived neurotrophic factor mimetic 7,8-dihydroxyflavone mitigates NLRP3 inflammasome activation and GSDMD-mediated pyroptosis and enhances the negative regulatory pathways of pyroptosis in microglia
  6. LZTR1 interacts with AIFM3 protein and negatively regulates Ras signaling by downregulating SHOC2 and phosphorylated p90RSK protein levels in apoptosis
  7. A synonymous single nucleotide variant on the FAM20C gene causes non-lethal Raine syndrome
  8. Kaempferol reduces pyroptosis in acute lung injury by decreasing ADAM10 activity through the NLRP3/GSDMD pathway
  9. Genetically determined plasma trefoil factor-3 levels are causally associated with the risk of ulcerative colitis: a Mendelian randomization study
  10. A novel homozygous RIPK4 variant in a family with severe Bartsocas‐Papas syndrome
  11. Finding underlying genetic mechanisms of two patients with autism spectrum disorder carrying familial apparently balanced chromosomal translocations
  12. TAp73β Can Promote Hepatocellular Carcinoma Dedifferentiation
  13. RIPK4 suppresses the TGF‐β1 signaling pathway in HaCaT cells
  14. Integrated multi‑omics data analysis identifying novel drug sensitivity‑associated molecular targets of hepatocellular carcinoma cells
  15. Outcomes of long term treatments of type I hereditary angioedema in a Turkish family
  16. Role of Circulating Tumor Cells and Cell-Free Tumor Deoxyribonucleic Acid Fragments as Liquid Biopsy Materials in Breast Oncology
  17. Synthesis and bio-molecular study of (+)-N-Acetyl-α-amino acid dehydroabietylamine derivative for the selective therapy of hepatocellular carcinoma
  18. Role of Fanconi anemia/BRCA pathway genes in hepatocellular carcinoma chemoresistance
  19. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations
  20. Genome-Wide Transcriptional Reorganization Associated with Senescence-to-Immortality Switch during Human Hepatocellular Carcinogenesis
  21. Genetics and epigenetics of liver cancer